Benafentrine

This classification denotes a phosphodiesterase inhibitor with the molecular formula C23H27N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DXB7KMD1F, chemically known as 4-(1,2,3,4,4qbeta,10bbeta-hexahydro-8,9-dimethoxy-2-methylbenzo(c)(1,6)naphthyridin-6-yl)acetanilid but generally known as benafentrine, which bears US NIH Compound Identifier 3084603. European Medicines Agency schedules Benafentrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05697MIG. The term BENAFENTRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). BENAFENTRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benafentrine under HS 29339990 and SITC 51577. As of Q4 2014, BENAFENTRINE remains the US FDA Preferred Term for this commodity. Benafentrine bears US NLM identifiers UMLS ID C0050999 and NCI Concept Code C74346. SMILES: O(C1CC2C3C(N=C(C2CC1OC)C1CCC(NC(=O)C)CC1)CCN(C3)C)C.